
|
November 21 (Fri) 08:00-09:30 |
Concurrent Symposium 1 (Kidney/Pancreas)
ENG
What’s New in Antibody-Mediated Rejection |
Room 1 (Convention Hall A+B+C, 4F) |
|
|---|---|---|---|
| Chair(s) |
James Lan (University of British Columbia (UBC), Canada) Seungyeup Han (Keimyung University Dongsan Hospital, Korea) |
||
| 08:00-08:20 |
Role of NK Cells in Allograft Injury: ABMR and Microvascular Inflammation
Philip Halloran (Alberta Transplant Applied Genomics Center, Canada) |
CV Lecture Note | |
| 08:20-08:40 |
New Immunologic Test for ABMR
Minjeong Nam (Samsung Medical Center, Korea) |
CV Lecture Note | |
| 08:40-09:00 |
Reclassification of Allograft Rejection-Related Diagnoses
Takahiro Tsuji (Sapporo City General Hospital, Japan) |
CV Lecture Note | |
| 09:00-09:20 |
Management Strategy for Chronic ABMR
Tae Hyun Ban (Eunpyeong St. Mary’s Hospital, The Catholic University of Korea, Korea) |
CV Lecture Note | |
| 09:20-09:30 | Discussion | ||
|
November 21 (Fri) 08:00-09:30 |
Concurrent Symposium 2 (Liver)
ENG
Best LT Strategy for ALF and ACLF Patients |
Room 4 (Emerald Hall A, 3F) |
|
|---|---|---|---|
| Chair(s) |
Young Kyoung You (Seoul St. Mary’s Hospital, The Catholic University of Korea, Korea) Dong-Sik Kim (Korea University Anam Hospital, Korea) |
||
| 08:00-08:20 |
Surgeon's Perspective: Perioperative Management for Better Outcomes in ALF and ACLF
Seok-Hwan Kim (Chungnam National University Hospital, Korea) |
CV Lecture Note | |
| 08:20-08:40 |
Hepatologist’s Perspective - Proper Timing of LT for ALF/ACLF
Jae Seung Lee (Severance Hospital, Korea) |
CV Lecture Note | |
| 08:40-09:00 |
Waiting DDLT Vs. LDLT Under Severe Organ Shortage
Alfred Kow Wei Chieh (National University of Singapore, Singapore) |
||
| 09:20-09:30 | Discussion | ||
|
November 21 (Fri) 08:00-09:30 |
Concurrent Symposium 3 (Xenotransplantation)
ENG
Ethics, Legal, and Social Issues in Xenotransplantation |
Room 5 (Emerald Hall B, 3F) |
|
|---|---|---|---|
| Chair(s) |
Ik Jin Yun (Konkuk University Hospital, Korea) Hidetaka Hara (Transplantation Institute at the Second Affiliated Hospital, China) |
||
| 08:00-08:30 |
Legislation for the Xenotransplantation
Ivo Kwon (Ewha Womans University, Korea) |
CV Lecture Note | |
| 08:30-09:00 |
Public Attitude for the Xenotransplantation
Takashi Yokoo (Jikei University, Japan) |
CV Lecture Note | |
| 09:00-09:30 |
Ethical Barrier for the Xenotransplantation
Dianyuan Li (Nanjing Medical University Affiliated Suzhou Hospital, China) |
CV Lecture Note | |
|
November 21 (Fri) 08:00-09:30 |
Concurrent Symposium 4 (Basic)
ENG
Immune Regulation in Organ Transplantation |
Room 6 (Diamond Hall, 3F) |
|
|---|---|---|---|
| Chair(s) |
Eui-Cheol Shin (KAIST, Korea) Toshihito Hirai (Tokyo Women's Medical University, Japan) |
||
| 08:00-08:20 |
Spatial Omics for Kidney Rejection
Toshihito Hirai (Tokyo Women's Medical University, Japan) |
CV Lecture Note | |
| 08:20-08:40 |
Single Cell Transcriptomics of Allorejection
Hyun Je Kim (Seoul National University, Korea) |
CV Lecture Note | |
| 08:40-09:00 |
Immune Regulation by Cytoplasmic Domain of CTLA-4
Je-Min Choi (Hanyang University, Korea) |
CV Lecture Note | |
| 09:00-09:20 |
Immune Regulation Using Anti-CD154/CD28 Bispecific Antibody
Junho Chung (Seoul National University Hospital, Korea) |
CV Lecture Note | |
| 09:20-09:30 | Discussion | ||
|
November 21 (Fri) 10:00-10:30 |
Special Lecture 2
ENG
|
Room 1 (Convention Hall A+B+C, 4F) |
|
|---|---|---|---|
| Chair(s) | Ik Jin Yun (Konkuk University Hospital, Korea) | ||
| 10:00-10:30 |
The Chinese Frontier: Recent Breakthroughs in Clinical Xenotransplantation
Dengke Pan (Chengdu ClonOrgan Biotechnology Co. Ltd, China) |
CV Lecture Note | |
|
November 21 (Fri) 10:30-11:00 |
Keynote Lecture 1
ENG
|
Room 1 (Convention Hall A+B+C, 4F) |
|
|---|---|---|---|
| Chair(s) | Jong Soo Lee (Ulsan University Hospital, Korea) | ||
| 10:30-11:00 |
Collaborative Human-Mouse Studies on Desensitization and ABMR
Anita Chong (The University of Chicago, USA) |
CV Lecture Note | |
|
November 21 (Fri) 11:00-12:00 |
Plenary Session 1 (Best Papers)
ENG
|
Room 1 (Convention Hall A+B+C, 4F) |
|
|---|---|---|---|
| Chair(s) |
Dong Jin Joo (Severance Hospital, Korea) Byung Ha Chung (Seoul St. Mary’s Hospital, The Catholic University of Korea, Korea) |
||
| 11:00-11:15 |
Comparative Analysis of Liver Transplantation Outcomes in United States and South Korea: the UNOS and KOTRY Registry Analyses
Jiyoung Kim (The Catholic University of Korea Seoul St. Mary's Hospital, Korea) |
Abstract | |
| 11:15-11:30 |
Decoding Versatile Roles of XCR1+ Conventional Dendritic Cells in Liver Graft Injury, Repair and Regeneration
Zhoucheng Wang (Zhejiang University, China) |
Abstract | |
| 11:30-11:45 |
Pediatric Donor Kidney Risk Factors for Graft Loss in Pediatric Recipients of Deceased-Donor Kidneys
Qiang Zhang (The First Affiliated Hospital, Sun Yat-Sen University, China) |
Abstract | |
| 11:45-12:00 |
Pre-Transplant HLA-DQ Donor-Specific Antibodies: Differential Characteristics and Clinical Implications in Kidney Transplantation
Hanbi Lee (The Catholic University of Korea Seoul St. Mary's Hospital, Korea) |
Abstract | |
|
November 21 (Fri) 12:10-12:40 |
Living Legend Session
ENG
|
Room 1 (Convention Hall A+B+C, 4F) |
|
|---|---|---|---|
| Chair(s) | Jongwon Ha (Seoul National University Hospital, Korea) | ||
| 12:10-12:15 |
Introduction of Prof. Sang Joon Kim
Sangil Min (Seoul National University Hospital, Korea) |
||
| 12:15-12:30 | The Heart of a Pioneer: A Surgeon’s Journey of Hope and Healing (Movie) | ||
| 12:30-12:35 | Award Ceremony | ||
| 12:35-12:40 |
Acceptance Speech
Sang Joon Kim (Seoul National University, Korea) |
||
|
November 21 (Fri) 12:40-13:40 |
Luncheon Symposium 2 (Astellas Pharma Korea, Inc.)
ENG
Translating Drug Levels into Patient Outcomes in Tailored Immunosuppression |
Room 1 (Convention Hall A+B+C, 4F) |
|
|---|---|---|---|
| Chair(s) |
Chan Duck Kim (Kyungpook National University Hospital, Korea) Jae Berm Park (Samsung Medical Center, Korea) |
||
| 12:40-13:05 |
From Clinical Indicators to Tailored Therapy: Optimizing Immunosuppression in KT
Jin Hyuk Paek (Keimyung University Dongsan Hospital, Korea) |
CV | |
| 13:05-13:30 |
From Drug Levels to Patient Outcomes: Practical Strategies for TAC Optimization
Hyun-Jeong Kim (Severance Hospital, Korea) |
||
|
November 21 (Fri) 12:40-13:40 |
Luncheon Symposium 3 (Chong Kun Dang Pharm.)
ENG
|
Room 4 (Emerald Hall A, 3F) |
|
|---|---|---|---|
| Chair(s) | Kyu Ha Huh (Severance Hospital, Korea) | ||
| 12:40-13:40 |
Small Dose, Big Impact: Clinical Utility of 0.25mg Tacrolimus Formulation in Managing Variability and Drug Interactions
Jun Bae Bang (Ajou University Hospital, Korea) |
CV | |
|
November 21 (Fri) 13:40-14:40 |
AI in Medical Publication and Presentation
ENG
|
Room 1 (Convention Hall A+B+C, 4F) |
|
|---|---|---|---|
| Chair(s) | Seungyeup Han (Keimyung University Dongsan Hospital, Korea) | ||
| 13:40-14:10 |
Generative AI for Efficient Medical Research and Data Analysis
Hyunwook Kwon (Asan Medical Center, Korea) |
CV Lecture Note | |
| 14:10-14:40 |
Generative AI for Efficient Medical Research Writing
Jeong-Moo Lee (Seoul National University Hospital, Korea) |
CV Lecture Note | |
|
November 21 (Fri) 13:40-14:40 |
KOTRY Joint Symposium
ENG
|
Room 2 (Convention Hall D, 4F) |
|
|---|---|---|---|
| Chair(s) |
Myoung Soo Kim (Severance Hospital, Korea) Curie Ahn (National Medical Center, Korea) |
||
| 13:40-14:00 |
Expanding Transplant Registries Using National Health Data
Hyeon Seok Hwang (Kyung Hee University, Korea) |
CV Lecture Note | |
| 14:00-14:20 |
Implication of Integrating Transplant Registries Internationally
Hae-Young Lee (Seoul National University Hospital, Korea) |
||
| 14:20-14:40 |
Application of Artificial Intelligence to National Transplant Cohort
Tae Joon Jun (Asan Medical Center, Korea) |
CV Lecture Note | |
|
November 21 (Fri) 13:40-14:40 |
Woman In Transplantation (WIT) in KST
ENG
Work-Life Balance, and Job Satisfaction in the Transplantation Field |
Room 3 (Convention Hall E, 4F) |
|
|---|---|---|---|
| Chair(s) | Yeong Hoon Kim (Inje University Busan Paik Hospital, Korea) | ||
| 13:40-14:00 |
Study on Burnout, Work-Life Balance, and Job Satisfaction Among Healthcare Professionals in the Transplantation Field in the Asia-Pacific Region
Claire Junga Kim (Dong-A University, Korea) |
CV Lecture Note | |
| 14:00-14:15 |
The further Research of Work - Care Balance
Jong Mi Kim (Coventry University, UK) |
||
| 14:15-14:40 |
Panel Discussion
Song Yee Kim (Yonsei University, Korea) Battsetseg Gonchigjav (Tissue and Organ Transplantation Center for Health Development, Mongolia) Farnaz Nobi (Kidney Foundation of Bangladesh, Bangladesh) Rose Marie Liquete (National Kidney and Transplant Institute, Philippines) |
||
|
November 21 (Fri) 13:40-14:40 |
Oral Presentation 1 (Liver)
ENG
|
Room 4 (Emerald Hall A, 3F) |
|
|---|---|---|---|
| Chair(s) |
Tae-Seok Kim (Keimyung University Dongsan Hospital, Korea) Ju Dong Yang (Cedars‑Sinai Liver Disease & Transplant Center, USA) |
||
| 13:40-13:50 |
Is a Functional Liver Remnant Volume Below 30% an Absolute Contraindication for Laparoscopic Living Liver Donors?
Sukmin Gwon (Samsung Medical Center, Korea) |
Abstract | |
| 13:50-14:00 |
Liver Autotransplantation: Innovation, Feasibility, and Outcome Evidence
Eleonora Nieddu (University of Padova, Italy) |
Abstract | |
| 14:00-14:10 |
Clinical Feasibility of Living Donor Liver Transplantation in Patients With Acute-on-Chronic Liver Failure: an International Multicenter Study
Hye-Sung Jo (Korea University Anam Hospital, Korea) |
Abstract | |
| 14:10-14:20 |
Safety and Efficacy of Living Donor Liver Transplantation for Unresectable Cholangiocarcinoma
Takashi Ito (Graduate School of Medicine, Kyoto University, Japan) |
Abstract | |
| 14:20-14:30 |
Enhancing Hepatocyte Transplantation Through Inducing Host Hepatocyte Senescence by Lipid Nanoparticle-Delivered CRISPR-Cas9
Tianchen Lan (Zhejiang Chinese Medical University, China) |
Abstract | |
| 14:30-14:40 |
Digital Twin and AI-Driven Precision Modeling in Liver Transplantation: Advancing Predictive Medicine in Asia
Chitaranjan Mahapatra (Indian Institute of Technology Bombay, India) |
Abstract | |
|
November 21 (Fri) 13:40-14:40 |
Satellite Forum (공청회)
KOR
Proposal of New Criteria for Cross-Match Testing in Deceased Donor Allocation (뇌사자 신장배분에서 교차반응 실시 및 배제 기준 설정 방안) |
Room 5 (Emerald Hall B, 3F) |
|
|---|---|---|---|
| Chair(s) |
Jaeseok Yang (Severance Hospital, Korea) Jae Berm Park (Samsung Medical Center, Korea) |
||
| 13:40-14:10 |
뇌사자 신장배분에서 교차반응 실시 및 배제 기준 설정 방안
Eun Suk Kang (Samsung Medical Center, Korea) |
CV Lecture Note | |
| 14:10-14:40 |
Panel Discussion
Eun-Jee Oh (Seoul St. Mary’s Hospital, The Catholic University of Korea, Korea) Soojinna Choi (Chonnam National University Hospital, Korea) Sung Shin (Asan Medical Center, Korea) Hajeong Lee (Seoul National University Hospital, Korea) Bok Nyeo Kim (Samsung Medical Center, Korea) |
||
|
November 21 (Fri) 13:40-14:40 |
Oral Presentation 2 (Kidney/Pancreas)
ENG
|
Room 6 (Diamond Hall, 3F) |
|
|---|---|---|---|
| Chair(s) |
Sun Cheol Park (Seoul St. Mary’s Hospital, The Catholic University of Korea, Korea) Joon Seok Oh (Bongseng Memorial Hospital, Korea) |
||
| 13:40-13:50 |
Clinical Outcomes of Kidney Retransplantation in Elderly Recipients: A Nationwide Cohort Study from the Korean Organ Transplantation Registry
Hanbi Lee (The Catholic University of Korea Seoul St. Mary's Hospital, Korea) |
Abstract | |
| 13:50-14:00 |
Survival Benefit of ABO- or HLA- Incompatible Living Donor Kidney Transplantation Compared to Waiting for Deceased Donor Kidney Transplantation in Elderly Patients
Hwa-Hee Koh (Catholic Kwandong University International St. Mary's Hospital, Korea) |
Abstract | |
| 14:00-14:10 |
Kidney Paired Donation as a Strategy to Overcome HLA Barriers and Anatomical Constraints: A Case Series from a Single Center in Korea
Eunjeong Kang (Seoul National University Hospital, Korea) |
Abstract | |
| 14:10-14:20 |
From Referral to Waitlist: One-Year Outcomes in Deceased Donor Kidney Transplant Referrals at Singapore General Hospital
Chin Yee Lee (Singapore General Hospital, Singapore) |
Abstract | |
| 14:20-14:30 |
TacrolimusSirolimus Combined Exposure and Acute Rejection in Kidney Transplant Recipients Undergoing Early Conversion to Sirolimus: A Multicenter Threshold Analysis Running Title: TacSiro Exposure and Rejection After Early Sirolimus Conversion
Youngmin Ko (Asan Medical Center, Korea) |
Abstract | |
| 14:30-14:40 |
The Incidence of Delayed Graft Function in Kidney Transplantation: a Comparison Between Preoperative and Intraoperative Methylprednisolone Administration, Propensity Weighting Score
Sakared Tangroe (Vascular And Transplantation Unit, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand) |
Abstract | |
|
November 21 (Fri) 14:40-15:10 |
Mini-oral Presentation 1 (Liver)
ENG
|
E-poster Zone (Lobby, 4F) |
|
|---|---|---|---|
| Chair(s) | Seok-Hwan Kim (Chungnam National University Hospital, Korea) | ||
| 14:40-14:45 |
Biologically-Driven Multistep Approach for Recurrent Cholangiocarcinoma Leading to Liver Transplantation
Alessandro Furlanetto (Padua University, Italy) |
Abstract | |
| 14:45-14:50 |
Flavin Mononucleotide: A Complementary Marker for Liver Viability Evaluation
Alessia Lanubile (University of Padua, Italy) |
Abstract | |
| 14:50-14:55 |
Impact of Cold Ischemic Time on Rejection After Liver Transplantation: Is There a Safe Window?
Sehyeon Yu (Korea University Anam Hospital, Korea) |
Abstract | |
| 14:55-15:00 |
Treatment Strategies Including Liver Transplantation for Peliosis Hepatis and Cholestasis in X-Linked Myotubular Myopathy
Ayane Oshiro (National Center For Child Health And Development, Japan) |
Abstract | |
| 15:00-15:05 |
Clinical Impact of Desensitization in Liver Transplantation of Immunologically High Risk Recipients
Min Kyoung Kim (Seoul National University Hospital, Korea) |
Abstract | |
| 15:05:15:10 |
Integration of Portal Pressure and MELD Score Enhances Prediction of Early Graft Loss in LDLT
Junya Mita (Graduate School of Medical Sciences, Kyushu University, Japan) |
Abstract | |
|
November 21 (Fri) 14:40-15:10 |
Mini-oral Presentation 2 (Liver)
ENG
|
E-poster Zone (Lobby, 4F) |
|
|---|---|---|---|
| Chair(s) | Shinya Okumura (Kyoto University, Japan) | ||
| 14:40-14:45 |
Tacrolimus-Resistant Universal CAR-T Cells Mediate Anti-Tumor Immunity in Hepatocellular Carcinoma
Xinyang Zhong (Institute of Translational Medicine,Zheiiang University School of Medicine, China) |
Abstract | |
| 14:45-14:50 |
Diagnostic Performance of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation
Byeong-Gon Na (Asan Medical Center, Korea) |
Abstract | |
| 14:50-14:55 |
Donor-Derived Cell-Free DNA: A Noninvasive Indicator of Graft Injury, Rejection Severity, and Early Graft Failure Following Liver Transplantation
Eun-Ki Min (Severance Hospital, Korea) |
Abstract | |
| 14:55-15:00 |
Clinical Signicance of De Novo Malignancy After Liver Transplant: Update on a Single-Center Study
Jaeyoon Kim (Seoul National University Hospital, Korea) |
Abstract | |
| 15:00-15:05 |
Dcd Liver Transplantation With Elderly Donors in a Setting of 20 Minutes No-Touch Time: Case Series With Nonagenarian Grafts
Alessandro Furlanetto (Padua University, Italy) |
Abstract | |
| 15:05:15:10 |
Living Donor Liver Transplantation for a Choledochal Cyst Type IVa in a Young Adult: A Case Report
Su Min Jeon (Korea University Anam Hospital, Korea) |
Abstract | |
|
November 21 (Fri) 14:40-15:10 |
Mini-oral Presentation 3 (Kidney/Pancreas)
ENG
|
E-poster Zone (Lobby, 4F) |
|
|---|---|---|---|
| Chair(s) | Song-Yi Kim (Chungnam National University Hospital, Korea) | ||
| 14:40-14:45 |
Clinical Implications of Cardiovascular Events of Elderly Kidney Transplant Recipients: A Nationwide Cohort Study from South Korea
Sang Hun Eum (Incheon St. Mary's Hospital, The Catholic University of Korea, Korea) |
Abstract | |
| 14:45-14:50 |
Long-Term Impact of Vitamin D Deficiency on Clinical Outcomes in Kidney Transplant Recipients: Evidence from the KNOW-KT Cohort
Junghwa Ryu (Ewha Womans University Medical Center, Korea) |
Abstract | |
| 14:50-14:55 |
Recurrent, Non-Recurrent, and De Novo Membranous Nephropathy After Kidney Transplantation: A Systematic Review and Meta-Analysis
Aschariya Wipattanakitcharoen (Faculty of Medicine, Chulalongkorn University And King Chulalongkorn Memorial Hospital, The Thai Red Cross Society, Thailand) |
Abstract | |
| 14:55-15:00 |
Outcomes of ABO-Incompatible Kidney Transplantation in Recipients With Extremely High Baseline Isoagglutinin Titers (1:1024): A Two-Center Experience
Jee Sung Kim (The Catholic University of Korea Seoul St. Mary's Hospital, Korea) |
Abstract | |
| 15:00-15:05 |
Comparative Outcomes of Basiliximab and Rabbit Antithymocyte Globulin (rATG) for Induction in Deceased Donor Kidney Transplantation (DDKT): A Multicenter Retrospective Cohort Study
Eunju Jang (The Catholic University of Korea Seoul St. Mary's Hospital, Korea) |
Abstract | |
| 15:05:15:10 |
Optimizing Deceased Multi- Organ Donation: an Analysis of 2024 Referral Pathways and Strategies for Improvement
Rose Marie Liquete (National Kidney And Transplant Institute, Philippines) |
Abstract | |
|
November 21 (Fri) 14:40-15:10 |
Mini-oral Presentation 4 (Kidney/Pancreas)
ENG
|
E-poster Zone (Lobby, 4F) |
|
|---|---|---|---|
| Chair(s) | Hanbi Lee (Seoul St. Mary’s Hospital, The Catholic University of Korea, Korea) | ||
| 14:40-14:45 |
Systematic Review and Meta-Analysis of Late-Onset Pneumocystis Jirovecii Pneumonia in Kidney Transplant Recipients: Prevalence, Risk Factors and Graft Outcomes
Chanyanuch Rakpithayanon (Faculty of Medicine, Chulalongkorn University, Thailand) |
Abstract | |
| 14:45-14:50 |
HLA-A Homozygosity Increases the Risk of Cytomegalovirus Reactivation in Seropositive Kidney Transplant Recipients
Minyu Kang (Severance Hospital, Korea) |
Abstract | |
| 14:50-14:55 |
Stage Distribution and Survival of Urologic Cancers in Kidney Transplant and Dialysis Patients: A Nationwide Study Using the K-CURE Database
Heajung Lee (Yonsei University, Korea) |
Abstract | |
| 14:55-15:00 |
Building Global Collaboration: the Journey and Impact of Vitallink International
Jieun Oh (Kangdong Sacred Heart Hospital, Korea) |
Abstract | |
| 15:00-15:05 |
Comparative Analysis of Renal Transplant Outcomes: Living Related Vs. Non-Related Donors and the Impact of Consanguinity and HLA Matching Among Kidney Transplant Patients at NKTI: A Three-Year Retrospective Study
Jestha Marie Bernadette De Vera (National Kidney & Transplant Institute/ Tondo Medical Center, Philippines) |
Abstract | |
| 15:05:15:10 |
A Systematic Review on the Prevalance and Risk Determinants of Ureteral Stenosis in Kidney Transplant Recipients
Firtantyo Adi Syahputra (Fatmawati Hospital, Indonesia) |
Abstract | |
|
November 21 (Fri) 14:40-15:10 |
Mini-oral Presentation 5 (Lung)
ENG
|
E-poster Zone (Lobby, 4F) |
|
|---|---|---|---|
| Chair(s) | Samina Park (Seoul National University Hospital, Korea) | ||
| 14:40-14:45 |
The Impact of Intraoperative V-A ECMO Cannulation Strategy on Early Post-Transplant Outcomes and PGD: A Propensity Score-Matched Cohort Study
Junghee Lee (Samsung Medical Center, Korea) |
Abstract | |
| 14:45-14:50 |
Early Experience of Inhaled Treprostinil as a Bridge to Lung Transplantation in Pulmonary Hypertension Associated With Interstitial Lung Disease: a Single-Center Retrospective Study
Sodai Nagata (The University of Tokyo Hospital, Japan) |
Abstract | |
| 14:50-14:55 |
Lung Transplantation in Thailand: Early Steps, Hard Lessons, and Hope Ahead
Krittika Teerapuncharoen (Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand) |
Abstract | |
|
November 21 (Fri) 14:40-15:10 |
Mini-oral Presentation 6 (Xenotransplantation)
ENG
|
E-poster Zone (Lobby, 4F) |
|
|---|---|---|---|
| Chair(s) | Kyoung Sik Park (Konkuk University Hospital, Korea) | ||
| 14:40-14:45 |
Circulating Cell-Free DNA and Immune Monitoring for Optimizing Immunosuppression in QKO Pig-to-Monkey Islet Xenotransplantation
Ji-Jing Yan (Yonsei University College of Medicine, Korea) |
Abstract | |
| 14:45-14:50 |
Human NK Cell Activation and Cytotoxicity Against Wild-Type and Quadruple-Knockout Porcine PBMCs in Xenotransplantation
Seo-A Park (Graduate School of The Catholic University of Korea, Korea) |
Abstract | |
| 14:50-14:55 |
Future Investment Strategies for the Clinical Translation of Xenotransplantation in Korea
Ik Jin Yun (Konkuk University Medical Center, Korea) |
Abstract | |
| 14:55-15:00 |
Establishing the Asian Xenotransplantation Association to Promote Balanced Progress in Clinical Xenotransplantation
Ik Jin Yun (Konkuk University Medical Center, Korea) |
Abstract | |
| 15:00-15:05 |
The Impact of Housing Environment on Hematological Profiles of Transgenic Pigs for Xenotransplantation
Won Kil Lee (National Institute of Animal Science, Korea) |
Abstract | |
|
November 21 (Fri) 15:10-16:40 |
Concurrent Symposium 5 (Infection)
ENG
Recent Development in Transplant Pathology: Focusing on Kidney and Liver Transplantation |
Room 2 (Convention Hall D, 4F) |
|
|---|---|---|---|
| Chair(s) |
Sang Il Kim (Seoul St. Mary’s Hospital, The Catholic University of Korea, Korea) Ban Hock Tan (Singapore General Hospital, Singapore) |
||
| 15:10-15:30 |
Candida Auris, Is It Curable?
Kyung-Hwa Park (Chonnam National University Hospital, Korea) |
CV Lecture Note | |
| 15:30-15:50 |
Refractory/resistant CMV Infection
Michelle K Yong (Royal Melbourne Hospital, Australia) |
||
| 15:50-16:10 |
New Microbiologic Tests for Rapid Diagnosis
Ki Ho Hong (Severance Hospital, Korea) |
CV Lecture Note | |
| 16:10-16:30 |
New Antibiotics Against Carbapenem-Resistant Gram-Negative Bacteria
Young Kyung Yoon (Korea University Anam Hospital, Korea) |
||
| 16:30-16:40 | Discussion | ||
|
November 21 (Fri) 15:10-16:40 |
Concurrent Symposium 6 (Lung)
ENG
Recent Update of Lung Transplantation |
Room 3 (Convention Hall E, 4F) |
|
|---|---|---|---|
| Chair(s) |
Moo Suk Park (Severance Hospital, Korea) Unmil Shah (KIMS, India) |
||
| 15:10-15:30 |
Short Telomere Syndrome in Lung Transplantation
Jimyung Park (Seoul National University Hospital, Korea) |
CV Lecture Note | |
| 15:30-15:50 |
Diagnostic Role of Donor Derived Cell Free DNA in Lung Transplantation
Yu Jin Park (Severance Hospital, Korea) |
CV Lecture Note | |
| 15:50-16:10 |
Recent Definition of Lung Transplant: ALAD/BLAD
Woo Hyun Cho (Pusan National University Yangsan Hospital, Korea) |
CV Lecture Note | |
| 16:10-16:40 |
Panel Discussion
Ala Woo (Severance Hospital, Korea) Ji Eun Park (Ajou University Hospital, Korea) Sunghoon Park (Hallym University Sacred Heart Hospital, Korea) Sunmi Choi (Seoul National University Hospital, Korea) |
||
|
November 21 (Fri) 15:10-16:40 |
Concurrent Symposium 7 (Liver)
ENG
Current State of Pediatric Liver Transplantation in Asia |
Room 4 (Emerald Hall A, 3F) |
|
|---|---|---|---|
| Chair(s) |
Kyung Mo Kim (Asan Medical Center, Korea) Mureo Kasahara (National Center for Child Health and Development (NCCHD), Japan) |
||
| 15:10-15:30 |
Pediatric Liver Transplantation in Korea
Sanghoon Lee (Samsung Medical Center, Korea) |
CV Lecture Note | |
| 15:30-15:50 |
Pediatric Liver Transplantation in Japan
Mureo Kasahara (National Center for Child Health and Development (NCCHD), Japan) |
CV Lecture Note | |
| 15:50-16:10 |
Optimizing Peri-transplant Care to Improve Outcomes of Pediatric Liver Transplantation as a Pediatrician
Kyung Mo Kim (Asan Medical Center, Korea) |
CV Lecture Note | |
| 16:10-16:30 |
Beyond Survival: Nutrition, Growth and Longevity
Sowon Park (Asan Medical Center, Korea) |
CV Lecture Note | |
| 16:30-16:40 | Discussion | ||
|
November 21 (Fri) 15:10-16:40 |
Concurrent Symposium 8 (kidney/Pancreas)
ENG
AI and Personalized Medicine in Transplantation |
Room 5 (Emerald Hall B, 3F) |
|
|---|---|---|---|
| Chair(s) |
Chan Duck Kim (Kyungpook National University Hospital, Korea) Anil Chandraker (UMass Chan Medical School, USA) |
||
| 15:10-15:30 |
The Present and Future of Personalized Medicine
Yoonjae Choi (KAIST, Korea) |
CV Lecture Note | |
| 15:30-15:50 |
Personalized Approach for Immunologic Risk Assessment in Kidney Transplantation
James Lan (University of British Columbia (UBC), Canada) |
||
| 15:50-16:10 |
Personalized Approach to Immunosuppressive Therapy: Optimizing Treatment for Each Patient
Hyunwook Kwon (Asan Medical Center, Korea) |
CV Lecture Note | |
| 16:10-16:30 |
Prediction and Prevention of Post-Transplant Complications: Personalized Risk Assessment
Hye Eun Yoon (Seoul St. Mary’s Hospital, The Catholic University of Korea, Korea) |
CV Lecture Note | |
| 16:30-16:40 | Discussion | ||
|
November 21 (Fri) 15:10-16:40 |
Concurrent Symposium 9 (Basic)
ENG
Gene Editing Technology and Organ Transplantation |
Room 6 (Diamond Hall, 3F) |
|
|---|---|---|---|
| Chair(s) |
Hyongbum Kim (Yonsei University, Korea) Gue-Ho Hwang (Hanyang University, Korea) |
||
| 15:10-15:30 |
Basic Principle of Gene Editing
Hyongbum Kim (Yonsei University, Korea) |
CV Lecture Note | |
| 15:30-15:50 |
Gene Editing Technology and Human Diseases
Daesik Kim (Sungkyunkwan University, Korea) |
CV Lecture Note | |
| 15:50-16:10 |
Medical Applications of Gene Editing Technology
Gue-Ho Hwang (Hanyang University, Korea) |
CV Lecture Note | |
| 16:10-16:30 |
Gene Editing for Immune Evasion
Jae Young Lee (Sungkyunkwan University, Samsung Advanced Institute of Health Sciences and Technology (SAIHST), Korea) |
CV Lecture Note | |
| 16:30-16:40 | Discussion | ||
|
November 21 (Fri) 16:40-17:40 |
Special Symposium
ENG
Unusual Transplantation: Unleashing Imagination |
Room 1 (Convention Hall A+B+C, 4F) |
|
|---|---|---|---|
| Chair(s) | Kwang-Woong Lee (Seoul National University Hospital, Korea) | ||
| 16:40-17:00 |
Reconstructing Identity: The Science and Ethics of Facial Transplantation
JongWoo Choi (Asan Medical Center, Korea) |
CV Lecture Note | |
| 17:00-17:20 |
Restoring Functionality: Breakthroughs in VCA
Cheng-Hung Lin (Linkou Chang Gung Memorial Hospital, Taiwan) |
CV Lecture Note | |
|
November 21 (Fri) 16:40-17:40 |
Oral Presentation 3 (Xenotransplantation)
ENG
Solid organ Xenotransplantation |
Room 2 (Convention Hall D, 4F) |
|
|---|---|---|---|
| Chair(s) | Hyun Keun Chee (Konkuk University Hospital, Korea) | ||
| 16:40-16:50 |
CCL25 as a Candidate Plasma Biomarker of Antibody-Mediated Rejection in Pig-to-Primate Kidney Xenotransplantation
Kyu-Hyun Han (Yonsei University College of Medicine, Korea) |
Abstract | |
| 16:50-17:00 |
Immunomodulatory Potential of Pig-Derived Regulatory Macrophages in Xenotransplantation
Nhat Minh Dang (Gachon University Department of Life Science, Korea) |
Abstract | |
| 17:00-17:10 |
First Evidence of Dual Immunologic Effects of Rabbit Anti-Thymocyte Globulin in Xenotransplantation: Induction of Anti-Pig Antibodies and Cross-Reactivity With Triple-Knockout Pig Cells
Hongtao Jiang (Hainan Medical University, China) |
Abstract | |
| 17:10-17:20 |
Assessment of Three Dual Costimulatory Blockade Regimens for Reducing Rejection in Pig-to-Nonhuman Primate Kidney Xenotransplantation
Minhee Seong (Yonsei University College of Medicine, Korea) |
Abstract | |
| 17:20-17:30 |
Development of Proteinuria Following 4GE Pig-to-Rhesus Monkey Kidney Xenotransplantation Leads to Loss of Anti-CD154 Antibody and Accelerates the Process of AMR
Man Zhang (Institute of Organ Transplantation, Tongji Hospital Tongji Medical College, Huazhong University of Science And Technology, China) |
Abstract | |
| 17:30-17:40 |
Analysis of Cross-Reactive Anti-SLA Antibodies in Allosensitized Human Sera Using Antibody Elution and Single Antigen HLA Bead Assay
Sang-Ik Cho (Graduate School of The Catholic University of Korea, Korea) |
Abstract | |
|
November 21 (Fri) 16:40-17:40 |
Oral Presentation 4 (Lung)
ENG
|
Room 3 (Convention Hall E, 4F) |
|
|---|---|---|---|
| Chair(s) |
Seiichiro Sugimoto (Okayama University, Japan) Sehoon Choi (Asan Medical Center, Korea) |
||
| 16:40-16:50 |
Direct and Continuous Temperature Monitoring of Donor Lungs During Static Ice Storage in Clinical Transplantation: an Observational Study With Physical Model Fitting
Junichi Takada (The University of Tokyo Graduate School of Medicine, Japan) |
Abstract | |
| 16:50-17:00 |
Lung Preservation at 10C Enhances Intraoperative ECMO Weaning and Enables Extended Preservation Time
Junghee Lee (Samsung Medical Center, Korea) |
Abstract | |
| 17:00-17:10 |
First Clinical Experience of Extended Ischemic Time Using 10C Static Storage in Lung Transplantation
Taeyoung Yun (Seoul National University Hospital, Korea) |
Abstract | |
| 17:10-17:20 |
Impact of First and Second Lung Ischemic Times on Primary Graft Dysfunction After Bilateral Lung Transplantation
Young Ho Yang (Yonsei University College of Medicine, Korea) |
Abstract | |
| 17:20-17:30 |
Characteristics, Risk Factors and Outcome of Chronic Lung Allograft Dysfunction After Lung Transplantation: Analysis of Korean Organ Transplantation Registry Cohort
Hye Min Kim (Severance Hospital, Korea) |
Abstract | |
|
November 21 (Fri) 16:40-17:40 |
Oral Presentation 5 (Liver)
ENG
|
Room 4 (Emerald Hall A, 3F) |
|
|---|---|---|---|
| Chair(s) |
Young Mok Park (Pusan National University Hospital, Korea) Chih-Chi Wang (Kaohsiung Chang Gung Memorial Hospital, Taiwan) |
||
| 16:40-16:50 |
CD40L-Targeted Nanoparticles Co-Delivering Sirolimus and CD28 siRNA for the Suppression of Allogeneic Liver Transplant Rejection
Xiandong Zeng (Renji Hospital, Shanghai Jiao Tong University School of Medicine, China) |
Abstract | |
| 16:50-17:00 |
Evaluation of Hepatitis B Recurrence in Liver Transplant Recipients in Vietnam
Linh Le (108 Military Central Hospital, Vietnam) |
Abstract | |
| 17:00-17:10 |
Liver Transplantation from Type 3 DCD Donors Aged Over 70 in Italy: Preliminary Analysis of a National Study
Alessandro Furlanetto (Padua University, Italy) |
Abstract | |
| 17:10-17:20 |
Impact of Pre-Transplant Radiation on Post-Transplant Biliary Complications in HCC Patients
Minha Choi (Asan Medical Center, Korea) |
Abstract | |
| 17:20-17:30 |
Non-Invasive cfDNA Chromatin Signatures Track Endothelial and Immune Injury in Liver Transplant Recipients
Javad Alizargar (National Taipei University of Nursing, Taiwan) |
Abstract | |
| 17:30-17:40 |
Human Leukocyte Antigen Allele Mismatch Can Predict T Cell-Mediated Rejection After Liver Transplantation: A Single-Center Retrospective Cohort Study in Japan
Ryo Ataka (Kyoto University Graduate School of Medicine, Japan) |
Abstract | |
|
November 21 (Fri) 16:40-17:40 |
Oral Presentation 6 (Kidney/Pancreas)
ENG
|
Room 5 (Emerald Hall B, 3F) |
|
|---|---|---|---|
| Chair(s) |
Ho Sik Shin (Kosin University Gospel Hospital, Korea) Sik Lee (Jeonbuk National University Hospital, Korea) |
||
| 16:40-16:50 |
COVID-19 Vaccination and SARS-CoV-2 Outcomes in End-Stage Renal Disease: A Nationwide Study from South Korea
Eunjeong Kwon (Seoul National University Bundang Hospital, Korea) |
Abstract | |
| 16:50-17:00 |
Association Between Systolic Blood Pressure Time in Target Range and Graft Outcomes in Kidney Transplant Recipients
Hee Byung Koh (Severance Hospital, Korea) |
Abstract | |
| 17:00-17:10 |
SGLT2 Inhibitors and the Risk of Urinary Tract Infections in Kidney Transplant Recipients: A Propensity Score Matched Multicenter Cohort Study
You Hyun Jeon (Kyungpook National University Hospital, Korea) |
Abstract | |
| 17:10-17:20 |
Early Tacrolimus Time in Therapeutic Range and Risk of Delayed Graft Function After Kidney Transplantation
Hyung Duk Kim (The Catholic University of Korea Eunpyeong St. Mary's Hospital, Korea) |
Abstract | |
| 17:20-17:30 |
Frailty and Quality of Life in Long-Term Kidney Transplant Survivors: A Prospective Cohort Study
Young Jin Yoo (Severance Hospital, Korea) |
Abstract | |
| 17:30-17:40 |
Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Early-Phase Kidney Transplant Recipients Receiving Tacrolimus: Development of a Practical Abbreviated AUC Model
Tanat Lertussavavivat (Chulalongkorn University, Faculty of Medicine, Thailand) |
Abstract | |
|
November 21 (Fri) 16:40-17:40 |
Oral Presentation 7 (Basic)
ENG
|
Room 6 (Diamond Hall, 3F) |
|
|---|---|---|---|
| Chair(s) |
Hokeun Kwon (Yonsei University, Korea) Byung Ha Chung (Seoul St. Mary’s Hospital, The Catholic University of Korea, Korea) |
||
| 16:40-16:50 |
Raising Awareness About Organ Donation and Transplantation Among Healthcare Professionals at 108 Military Central Hospital: A Single Experience Center in Vietnam
Linh Nguyen Thi Thuy (108 Military Central Hospital, Vietnam) |
Abstract | |
| 16:50-17:00 |
Development of Hypoimmunogenic hiPSC-Derived Liver Modules for Immune-Evasive Transplantation
Hee Ju Kim (Hanyang University Medical Center, Korea) |
Abstract | |
| 17:00-17:10 |
NK2 and NK3 Subtype Enrichment in Antibody-Mediated Rejection: Insights from Single-Cell Transcriptomics
Jin-Myung Kim (Asan Medical Center, Korea) |
Abstract | |
| 17:10-17:20 |
Gene Therapy Approaches for Human Leukocyte Antigen Class I Silencing to Promote Long-Term Liver Transplant Survival
Alessia Lanubile (University of Padua, Italy) |
Abstract | |
| 17:20-17:30 |
Sustained Expansion of Human Chemically Derived Hepatic Progenitors (hCdHs) Through Anti-Fibrotic Effect of Drug A
Seunghee Kim (Hanyang University Medical Center, Korea) |
Abstract | |
| 17:30-17:40 |
Mit-001 Protects Against Ischemia Reperfusion Induced Renal Fibrosis Via Antiinflammatory and Antiferroptotic Effects
Janghyun Jo (Chungnam National University, Korea) |
Abstract | |
|
November 21 (Fri) 17:40-18:10 |
General Assembly
ENG
|
Room 6 (Diamond Hall, 3F) |
|
|---|---|---|---|
Log in to ATW 2025 Website > Click on “My Page > Registration”, and click on the Certificate of Attendance button to download
On-site RegistrantsPlease request your certificate to the secretariat at reg@atweek.org
Visit the photo gallery to see highlights from
the congress and relive the unforgettable moments.
This website is operated by the secretariat (hereafter referred to as ‘SECRETARIAT’ or ‘We’) of the ATW 2025 (hereafter referred to as ‘MEETING’), and this privacy policy applies to this website only.
At atweek.org (hereafter referred to as ‘WEBSITE’), the SECRETARIAT respects its participants and understands that you are concerned about privacy. We are posting this privacy policy to let you know what kind of information we collect, how it is handled, with whom it may be shared, what choices you have regarding the SECRETARIAT’s use of your information, and how you may access some of the data you provide to the SECRETARIAT.
As the SECRETARIAT continues to develop the WEBSITE and take advantage of technologies to improve the services we offer, the privacy policy may change. We therefore encourage you to refer to this policy on an ongoing basis so that you understand the SECRETARIAT’s current privacy policy.
If you have any questions about this policy, please contact our Privacy Protection Manager at atweek@insession.co.kr
What Information Do We Collect? The SECRETARIAT collects various types of information depending upon how you use the WEBSITE:
A cookie is a small piece of information sent by a website, which is saved on your hard disk by your computer's browser. It holds information a site may need to interact with you and personalize your experience. At the WEBSITE, we use two kinds of cookies: session cookies and persistent cookies. Session cookies exist only for as long as your browser remains open. Once you exit your browser, they go away. The SECRETARIAT uses session cookies to maintain information we need to have in order for you to register for the MEETING. For example, the Session ID cookie that we ask your browser to hold retains the ID for My Page. Without the Session ID cookie, you cannot add and modify any information that you input at the time of your sign-up.
Persistent cookies, in contrast, last from visit to visit; they do not go away when you exit your browser. At the WEBSITE, we use persistent cookies to give you a more personalized browse and to help you navigate the WEBSITE more efficiently. The SECRETARIAT will use your information to enhance your site experience. However, you can use the WEBSITE without accepting a persistent cookie. To do so, you should set your browser options to reject persistent cookies. Alternatively, you can set your browser to notify you when you receive a cookie, which gives you the opportunity to decide whether you want to accept it or not. In many instances, the Help button on your browser toolbar will tell you how you can take these steps.
Cookies can be used by a website to recognize you. But that does not necessarily mean any personal information is stored in the cookies. At the WEBSITE, we store no personal information about you in the cookies. Anything you choose to tell us about yourself (such as your address and email address) is stored safely and separately on our secured servers, and you need to provide a password to access it.
The SECRETARIAT also uses cookies to look at how groups, rather than individuals, use the WEBSITE. In our administration page, we can observe which aisles and departments are most heavily trafficked and determine the best method to improve the experience for visitors. On the web, cookies help us develop a similar understanding so that we can continue to improve the arrangement, product offerings, registration and abstract submission at the WEBSITE.
The SECRETARIAT may use your information in a number of ways, including the following:
The information gathered may be shared with the ATW 2025 Organizing Committee and our family associations. We also share the information with third parties, including responsible committees with which we have a relationship. For example:
In most of the above situations, these third parties will receive your information because you will be visiting their websites or using their links and, in doing so, you may provide information directly to them. You therefore should refer to their privacy policies to understand how they handle your information and what kinds of choices you have.
The SECRETARIAT also may share your personal information with outside companies that perform services for the MEETING. For example, we may retain an outside company to manage a database containing certain participants’ information or to create and distribute an email offering. In those situations, the outside party is performing work for the WEBSITE, and the SECRETARIAT includes language in its contracts stating that your information is to be used only to provide the services requested by the SECRETARIAT.
Additionally, the SECRETARIAT may share account or other information when we believe it is necessary to comply with law or to protect the SECRETARIAT’s interests or property. This may include sharing information with other companies, committees, lawyers, credit bureaus, agents or government agencies in connection with issues related to fraud, credit or debt collection.
In the event that some or all of the business assets of the MEETING are sold or transferred, we generally would transfer the corresponding information about the participants of the MEETING.
Finally, the SECRETARIAT may share your personal information with unrelated outside companies so that they can directly promote the services to you if we feel that the companies offer services that we believe may be of interest. We also may provide you with the opportunity to create account on our website to receive email offers from other companies.
What Choices Do You Have Regarding the Use of Your Information? The SECRETARIAT provides you with a number of choices regarding our handling of your personal information. If you wish to change your email preferences, please click on the unsubscribe link at the bottom of any SECRETARIAT’s e-mail and describe the request such as “Please do not send me email," or “Keep my email address private."
Note: Once you have submitted your email opt-out request, you should assume that it has been successfully received and your request is being processed. Please allow us 10 business days from when the request is received to complete the removal, as some of our promotions may already have been in process before you submitted your request.
You also may use the address and phone number above to request that we not reveal your personal information to unrelated third parties for marketing purposes. If you choose to write to the SECRETAIAT, please include your name, address, and credit card account number to be used for settlement and state "NO THIRD PARTY SHARING" in your request.
If you are a user who has already signed up for the MEETING, you can update your information in “My Page,” and if you have questions about your status, you may also check them online in “My Page.”
If you would like, you may also an email to the SECRETARIAT.
Questions regarding your charge account may be forwarded to our Credit Customer Service Department.
The SECRETARIAT has put in place various physical, electronic, and managerial procedures to try to safeguard and secure the information we collect online. For example, private account and customer information is located on a secured server behind a firewall; it is not directly connected to the Internet. Encryption is a process by which a message or information is scrambled while it is in transit to the SECRETARIAT. It is based on a key that has two different parts, public and private. The public part of the key is distributed to those with whom you want to communicate. The private part is for the recipient's use only. So long as you use a browser that allows for encryption, when you send personal information to the SECRETARIAT, you use a public key to encrypt your personal information. If your information is intercepted during the transmission, it is scrambled and very difficult to decrypt. Once we receive your encrypted personal information, we use the private part of our key to decode it.
Please note however that while we implement many security measures on this site, 100% security cannot be guaranteed.
Thank you for your visit to the WEBSITE. If you have any questions or comments about this policy, please email the SECRETARIAT (atweek@insession.co.kr).
ATW 2025 will be held in Seoul, November 20 to November 22 in 2025. Your use of atweek.org will always be subject to, at a minimum, the terms and conditions set out in this document. These are referred to as the "Master Terms." In addition, your use of the Website may also be subject to the terms of any legal notice applicable to the Website in addition to the Master Terms. All such terms supplementing these Master Terms are referred to below as "Additional Terms." The Master Terms, together with any Additional Terms, form a binding legal agreement between you and ATW 2025 in relation to your use of the Website. Collectively, this legal agreement is referred to below as the "Terms." If there is any contradiction between the Additional Terms and the Master Terms, then the Additional Terms shall take precedence in relation to the Website to which the Additional Terms apply.
Your access or use of atweek.org in any way signifies that you have read, understand, and agree to be bound by the terms. By accessing or using atweek.org, you also represent that you have the legal authority to accept the Terms on behalf of yourself and any party you represent in connection with your use of the Website. If you do not agree to the Terms, you are not authorized to use the Website.
ATW 2025 may change, remove, add to modify the Terms, and reserves the right to do so in its discretion. In that case, we will post the updated Master Terms or Additional Terms, as relevant, to the Website and indicate the date of revision. We may send a message to your email address, or we may display a notice on the Website indicating that the Terms have changed. All amended Terms take effect immediately. If you do not agree with any modification to the Terms, you may terminate this agreement by ceasing use of the Website. Your continued use of the Website after the revised Terms are effective indicates that you have read, understood, and agreed to those Terms.
ATW 2025 makes the Website available to you on the Terms. You may only use the Website in accordance with these Master Terms and any applicable Additional Terms. In particular but without limitation, you may not use the Website for any purpose that is unlawful or prohibited by these Master Terms, any applicable Additional Terms, or any other conditions or notices that are made available on any Website.
The Website Services are controlled and offered by ATW 2025 in Korea. ATW 2025 makes no representations that the Website is appropriate or available for use in other locations. If you are accessing or using any Website from other jurisdictions, you do so at your own risk and you are responsible for compliance with local laws.
You understand that all material, data, and information, (collectively, "Content") which you may have access to through your use of the Website are the sole responsibility of the person from which such Content originated. This includes assertions that persons may make, expressly or impliedly, about the provenance and ownership of Content that they supply, upload, list and/or link to. You acknowledge that ATW 2025 does not make any representations or warranties about the accuracy, integrity or quality of the Content made available at the instigation of users of the Website. You understand that by using the Website, you may be exposed to Content that is offensive, indecent or objectionable. Under no circumstances is ATW 2025 liable in any way for any Content, including but not limited to: any infringing Content, any errors or omissions in Content, or for any loss or damage of any kind incurred as a result of the use of any Content posted, transmitted to, linked to or otherwise accessible or made available via the Website Services.
Content You Provide.You may only submit Content to the Website. This means that you can only submit Content that you yourself create, that is in the public domain or that you have been expressly granted the right to submit consistent with the Terms. For the avoidance of doubt, Content that infringes the rights of any third party must not be submitted. You represent, warrant, and agree that no Content of any kind submitted, posted or otherwise shared by you on or through any of the Website Services, violates or infringes upon the rights of any third party, including copyright, trademark, privacy, publicity or other personal or proprietary rights, or contains libelous, defamatory or otherwise unlawful material. Further, you represent, warrant, and agree not to submit any personally identifiable information. ATW 2025 may review your submissions and may delete or remove without notice any Content in its sole discretion that ATW 2025 determines violates the Terms or that may be offensive, illegal, or that might violate the rights, harm or threaten the safety of others. ATW 2025 does not endorse or support any Content posted by you. You alone are responsible for creating backup copies and replacing any Content you post on the Website, and you authorize ATW 2025 to make copies of your Content as we deem necessary in order to facilitate the posting of your Content on the Website.
Use of Content on the Website.You represent and warrant to ATW 2025 that you will use any and all Content on our Website in accordance with the applicable license. By using the Website, you agree that you are solely responsible for your use of any and all Content made available thereon. You agree that you must evaluate, and bear all risks associated with, the use of any Content, including any reliance on the provenance, ownership, accuracy, completeness or reliability of such Content. In this regard, you acknowledge that you may not rely on any Content made available on the Website without your own independent evaluation of that Content. ATW 2025 does not guarantee that Content made available on the Website does not infringe the rights of any third party.
By registering for an account on the Website, you agree to abide by all of the terms and conditions of these Master Terms and any applicable Additional Terms. ATW 2025 reserves the right to modify or discontinue the accounts of Registered Users and related Services at any time. ATW 2025 disclaims any and all liability to Registered Users.
SecurityYou agree to (a) provide accurate, current and complete information about you, if and as may be prompted by the registration process on the Website, (b) maintain the security of your password and identification, (c) maintain and promptly update your registration information and any other information you provide, and to keep it accurate and complete to, among other things, allow us to contact you, and (d) be fully responsible for all use of your account and for any actions that take place using your account. You may not set up an account or membership on behalf of another individual or entity.
Termination and Inactivation of User Accounts.Your participation as a Registered User terminates automatically upon your breach of any of these Master Terms or applicable Additional Terms. In addition, ATW 2025 may, at any time: (a) modify, suspend or terminate the operation of or access to your user account for any reason; (b) modify or change the Website and Services and any applicable Terms and policies governing your user account and related Website Services for any reason; and (c) interrupt user accounts and related Website Services for any reason, all as ATW 2025 deems appropriate in its discretion. Your access to your account and use of the Website may be terminated by you or by ATW 2025 at any time and for any reason whatsoever without notice. In addition, ATW 2025 reserves the right to delete and purge any account and all Content associated therewith following any prolonged period of inactivity, all as may be determined by ATW 2025 in its complete discretion.
To the fullest extent permitted by the applicable law, ATW 2025 offers the Website and Services as-is and makes no representations or warranties of any kind concerning the Website Services. ATW 2025 does not warrant that the functions or content contained on the Website will be uninterrupted or error-free, that defects will be corrected, or that ATW 2025's servers are free of viruses or other harmful components. ATW 2025 does not warrant or make any representation regarding use or the result of use of the Content in terms of accuracy, reliability, or otherwise.
ATW 2025 shall not be responsible or liable whatsoever in any manner for any Content posted on the Website for your use of the Website Services.
ATW 2025 is committed to handling responsibly the information and data we collect through our Website and agrees to use your personal information in accordance with the Privacy Policy. The Privacy Policy is hereby incorporated by reference into these Master Terms.
ATW 2025 respects the intellectual property rights of others, and we prohibit users of our Website from submitting, uploading, posting or otherwise transmitting any materials that violate another person's intellectual property rights.
These Master Terms and any Additional Terms will continue to apply until terminated by either you or ATW 2025 as set out below. Your right to access and use the Website terminates automatically upon your breach of any of these Master Terms or Additional Terms that may apply to any of the Website Services. ATW 2025 may, at any time: (a) modify, suspend or terminate the operation of or access to any of the Website Services, or any portion of the Website Services, for any reason; (b) modify or change the Website Services, or any portion of the Website Services, and any Master Terms, Additional Terms, and other policies governing the use of the Website Services, for any reason; (c) interrupt the operation of the Website Services, or any portion of the Website Services, for any reason, all as ATW 2025 deems appropriate in its sole discretion. Your access to, and use of, the Website Services may be terminated by you or by ATW 2025 at any time and for any reason. ATW 2025 will use reasonable efforts to notify you in advance about any material modification, suspension or termination by ATW 2025 that is not caused by your breach of the Terms.
This Master Term constitutes the entire agreement between you and ATW 2025 relating to this subject matter and supersedes all prior, contemporaneous, and future communications between you and ATW 2025.
These Terms of Use are Effective as of May 23, 2025.